Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial

NCT02448550 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention

Interventions

DRUG: Bivalirudin
DRUG: Unfractionated heparin

Sponsor

Kaiser Permanente